Innovage/$INNV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Innovage

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

Ticker

$INNV
Sector
Primary listing

Employees

2,440

Innovage Metrics

BasicAdvanced
$699M
-
-$0.22
0.52
-

What the Analysts think about Innovage

Analyst ratings (Buy, Hold, Sell) for Innovage stock.

Bulls say / Bears say

InnovAge’s census rose to roughly 7,740 participants as of June 30, 2025, up from 7,020 a year earlier, showing ongoing enrollment growth in its PACE program (GlobeNewswire).
Total revenue for FY 2025 reached $853.7 million, marking an 11.8% increase year-over-year, reflecting strong top-line momentum (GlobeNewswire).
Adjusted EBITDA for FY 2025 more than doubled to $34.5 million, with margins widening to 4.0% from 2.2% in FY 2024, indicating better operational leverage (GlobeNewswire).
InnovAge’s net loss widened 52% to $35.3 million in FY 2025, with the net loss margin rising to 4.1%, underscoring ongoing unprofitability despite revenue growth (GlobeNewswire).
Loss before income taxes increased to $34.0 million, representing 4.0% of revenue against 2.9% in FY 2024, indicating mounting bottom-line pressure (GlobeNewswire).
External provider costs and cost of care, excluding depreciation and amortization, accounted for approximately 82% of revenue in FY 2025, fueled by higher labor and medical inflation, which could pressure future margins (SEC).
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2025.

Innovage Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Innovage Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $INNV

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs